Skip to content
6 physician-led programs. Care and medication, both priced before you start.See all programs
GLP-1 library · Vayra

The GLP-1 reference, the same standard of care.

Vayra prescribes branded Wegovy®, Zepbound®, and Mounjaro® for chronic weight management, and Ozempic® for patients with type-2 diabetes. Your membership covers physician care and labs; your branded medication is priced separately and shown with the total.

Branded GLP-1

Why our GLP-1 program uses FDA-approved branded medication.

This brand-only stance is specific to GLP-1. Compounded semaglutide and tirzepatide are restricted, and are lawful only when a documented clinical difference cannot be met by an FDA-approved product. Cost, insurance denial, and patient preference are not lawful clinical differences.

For the vast majority of patients, the FDA-approved branded product, Wegovy®, Zepbound®, or Mounjaro® (and Ozempic® where T2D is the indication), is the right standard of care. That is why our GLP-1 program prescribes the branded product rather than compounded semaglutide or tirzepatide. In other Vayra programs, your physician may prescribe an individualized, physician-directed 503A compounded option when it is clinically appropriate, determined at your visit (503A preparations are not FDA-approved).

Your Vayra membership covers your physician care and your labs; your branded medication is priced separately and shown with the total, one integrated program with the same physician from your first visit onward.

HIPAA compliant
Licensed physicians in 40+ states
Licensed Pharmacy · Partner
No insurance billing · FSA / HSA eligible

Begin a documented physician visit.

Continuity is a priority, you will see the same physician whenever clinically possible. 45-min initial visit, 30-min monthly check-ins, unlimited secure messaging. Private clinical practice, no insurance billing.